SCHEMBL30502979

SCHEMBL30502979

N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 2/20 0.61
▸ OPRD1 P41143 2/20 0.61
▸ ACE P12821 2/20 0.60
▸ ECE1 P42892 8/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30502988 0.93 OPRM1 (0.64) OPRM1OPRD1ACEECE1
SCHEMBL31038379 0.93 OPRM1 (0.66) OPRM1OPRD1ACE
SCHEMBL30288044 0.91 ACE (0.68) ACEECE1
SCHEMBL30287996 0.91 ACE (0.68) ACEECE1
SCHEMBL30502977 0.91 OPRD1 (0.69) OPRM1OPRD1ACE
SCHEMBL31184558 0.90 ACE (0.69) ACEECE1
SCHEMBL14957660 0.90 ACE (0.69) ACEECE1
SCHEMBL29511092 0.90 ACE (0.69) ACEECE1
SCHEMBL9447245 0.90 ACE (0.69) ACEECE1
SCHEMBL28336599 0.90 ACE (0.69) ACEECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4615511-A1 TARGETED LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME TargImmune Therapeutics AG (CH) 2025-09-17 — — EP disclosed
EP-4615510-A1 POLYPLEXES OF NUCLEIC ACIDS AND TARGETED CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL TargImmune Therapeutics AG (CH) 2025-09-17 — — EP disclosed
EP-4426358-A2 TARGETED LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME TargImmune Therapeutics AG (CH) 2024-09-11 — — EP disclosed
WO-2024100046-A1 TARGETED LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME TARGIMMUNE THERAPEUTICS AG (CH) 2024-05-16 — — WO disclosed
WO-2024100044-A1 POLYPLEXES OF NUCLEIC ACIDS AND TARGETED CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL TARGIMMUNE THERAPEUTICS AG (CH) 2024-05-16 — — WO disclosed
WO-2023079142-A2 TARGETED LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME TARGIMMUNE THERAPEUTICS AG (CH) 2023-05-11 — — WO disclosed
Send feedback